Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00677222 · ClinicalTrials.gov registry record · Phase 1
Safety Study of AMI MultiStem® to Treat Heart Attacks
A Phase 1 study, sponsored by Healios K.K..
- Completed
- Registry status
- Phase 1
- Development phase
- 25
- Enrollment target
NCT00677222 is a Phase 1 study that has completed, run by Healios K.K.. The registered enrollment target is 25 participants.
The verdict
NCT00677222, a Phase 1 study, has completed, sponsored by Healios K.K..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 25 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if escalating doses of AMI MultiStem® delivered by catheter can safely be given to patients that have had a recent heart attack treated with stent implantation.
Interventions
- BIOLOGICAL AMI MultiStem®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00677222
The ClinicalTrials.gov registry entry for NCT00677222 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Healios K.K., which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AMI MultiStem® is the first listed.
NCT00677222 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00677222 about?
NCT00677222 is a clinical study titled "Safety Study of AMI MultiStem® to Treat Heart Attacks". The purpose of this study is to determine if escalating doses of AMI MultiStem® delivered by catheter can safely be given to patients that have had a recent heart attack treated with stent implantation.
What is the current status of trial NCT00677222?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 25 participants. The study started on 2008-05. Estimated completion is 2012-02.
What interventions are being tested in trial NCT00677222?
The interventions under investigation include: AMI MultiStem® (BIOLOGICAL).
Who is sponsoring clinical trial NCT00677222?
This trial is sponsored by Healios K.K., which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.